The Federal Reserve's Two-Day Policy Meeting Started Tuesday—Here's What You Need to Know
The Federal Open Market Committee meeting started Tuesday and will culminate with a written policy statement and press ...
GV Wire1h
Stock Market Today: Back Down Goes Wall Street as Big Tech Resumes Its Slide
Wall Street experiences another downturn as tech giants lead the market slide, raising concerns about economic stability.
CNET1h
Will Tomorrow's Fed Decision Matter for Mortgage Rates? It's Complicated
There's a lot of uncertainty in today's economy, but one thing is certain: The Federal Reserve isn't planning to lower ...
Stock market dips at open as Fed meets. No rate cut's expected but outlook will be key.
U.S. stocks open lower, consolidating recent gains, as focus turns to the Fed's policy meeting and economic projecions. No ...
Invesco Global Allocation Fund Q4 2024 Commentary
Invesco Global Allocation Fund Class A shares at NAV had a negative return in the fourth quarter and underperformed its style-specific benchmark, the Custom Invesco Global Allocation Index.
BIZD: The Simplest Way To Maintain BDC Exposure Through Market Uncertainty
VanEck BDC Income ETF offers diverse exposure to business development companies. Read why I maintain my buy rating on BIZD fund.
Once the Stock Market’s Fixation, Fed Day Takes on a New Meaning
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world This ...
Exelixis, Inc. (EXEL): Among the Best Biotech Stocks to Buy According to Billionaires
We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Exelixis, Inc.